Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Stepanova

Showing results (71-80 of 242) with videos related to

Pageof 25
Sort By:
Journal of Clinical and Experimental Hepatology|May 10, 2022
Health-Related Quality of Life and Health Care Resource Utilization in Patients With Chronic Liver Disease and Primary Liver Cancer in the United States: Analysis of Medical Expenditure Panel SurveyIssah Younossi, Maria Stepanova, Mercedes Walters, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 5, 2017
Patient-reported outcomes in patients co-infected with hepatitis C virus and human immunodeficiency virus treated with sofosbuvir and velpatasvir: The ASTRAL-5 studyZobair M Younossi, Maria Stepanova, Mark Sulkowski, et al.
Journal of Translational Medicine|February 9, 2012
The impact of IL28B genotype on the gene expression profile of patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirinZobair M Younossi, Aybike Birerdinc, Mike Estep, et al.
Journal of Clinical Gastroenterology|March 19, 2014
Trends in outpatient resource utilizations and outcomes for Medicare beneficiaries with nonalcoholic fatty liver diseaseZobair M Younossi, Li Zheng, Maria Stepanova, et al.
Clinical Transplantation|October 15, 2016
Long-term outcomes of heart transplant recipients with hepatitis C positivity: the data from the U.S. transplant registryMaria Stepanova, Trevor Locklear, Nila Rafiq, et al.
Medicine|August 19, 2016
Quality of life of Japanese patients with chronic hepatitis C treated with ledipasvir and sofosbuvirZobair M Younossi, Maria Stepanova, Masao Omata, et al.
Annals of Hepatology|January 1, 2014
Predictors of chronic liver disease in individuals with human immunodeficiency virus infectionNila Rafiq, Maria Stepanova, Brian Lam, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 5, 2015
Effects of Viral Eradication With Ledipasvir and Sofosbuvir, With or Without Ribavirin, on Measures of Fatigue in Patients With Chronic Hepatitis C Virus InfectionLynn Gerber, Michael Estep, Maria Stepanova, et al.
JAMA Internal Medicine|July 1, 2014
The portrait of an adult liver transplant recipient in the United States from 1987 to 2013Maria Stepanova, Homan Wai, Sammy Saab, et al.
Transplantation|September 24, 2013
Inpatient economic and mortality assessment for liver transplantation: a nationwide study of the United States data from 2005 to 2009Homan Wai, Maria Stepanova, Sammy Saab, et al.
Pageof 25

Showing results (71-80 of 242) with videos related to

Sort By:
Pageof 25
Journal of Clinical and Experimental Hepatology|May 10, 2022
Health-Related Quality of Life and Health Care Resource Utilization in Patients With Chronic Liver Disease and Primary Liver Cancer in the United States: Analysis of Medical Expenditure Panel SurveyIssah Younossi, Maria Stepanova, Mercedes Walters, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 5, 2017
Patient-reported outcomes in patients co-infected with hepatitis C virus and human immunodeficiency virus treated with sofosbuvir and velpatasvir: The ASTRAL-5 studyZobair M Younossi, Maria Stepanova, Mark Sulkowski, et al.
Journal of Translational Medicine|February 9, 2012
The impact of IL28B genotype on the gene expression profile of patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirinZobair M Younossi, Aybike Birerdinc, Mike Estep, et al.
Journal of Clinical Gastroenterology|March 19, 2014
Trends in outpatient resource utilizations and outcomes for Medicare beneficiaries with nonalcoholic fatty liver diseaseZobair M Younossi, Li Zheng, Maria Stepanova, et al.
Clinical Transplantation|October 15, 2016
Long-term outcomes of heart transplant recipients with hepatitis C positivity: the data from the U.S. transplant registryMaria Stepanova, Trevor Locklear, Nila Rafiq, et al.
Medicine|August 19, 2016
Quality of life of Japanese patients with chronic hepatitis C treated with ledipasvir and sofosbuvirZobair M Younossi, Maria Stepanova, Masao Omata, et al.
Annals of Hepatology|January 1, 2014
Predictors of chronic liver disease in individuals with human immunodeficiency virus infectionNila Rafiq, Maria Stepanova, Brian Lam, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 5, 2015
Effects of Viral Eradication With Ledipasvir and Sofosbuvir, With or Without Ribavirin, on Measures of Fatigue in Patients With Chronic Hepatitis C Virus InfectionLynn Gerber, Michael Estep, Maria Stepanova, et al.
JAMA Internal Medicine|July 1, 2014
The portrait of an adult liver transplant recipient in the United States from 1987 to 2013Maria Stepanova, Homan Wai, Sammy Saab, et al.
Transplantation|September 24, 2013
Inpatient economic and mortality assessment for liver transplantation: a nationwide study of the United States data from 2005 to 2009Homan Wai, Maria Stepanova, Sammy Saab, et al.
Pageof 25